Dr. Yu Tian Wang
founder
Clinical Sciences
Primary Peptides
Canada
Biography
Dr. Yu Tian Wang is a professor in the Department of Medicine and the Brain Research Centre at the University of British Columbia and the holder of the Heart and Stroke Foundation of B.C. & Yukon Chair in Stroke Research. He has also been a Howard Hughes Medical Institute International Scholar (2001-2011) and a Fellow of the Academy of Sciences of Royal Society of Canada since 2006. Dr. Wang’s research focuses on understanding the molecular mechanisms responsible for regulating the function and intracellular trafficking of neurotransmitter receptors critical for brain functions, such as learning, memory and cognition, and investigating the manner by which these mechanisms may be altered in central nervous disease processes. His goal is to be able to treat central nervous disorders such as stroke, epilepsy and drug addiction by designing new therapeutics which specifically target these receptors and their pathways. Dr. Wang has more than 10 years’ experience in biotech industry and company management. Dr. Wang is a co-founder of NoNO Inc, a peptide therapeutics company with a peptide drug currently in phase 3 clinical trial.
Research Interest
Clinical Sciences
